Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007770
Filing Date
2025-05-14
Accepted
2025-05-14 16:30:49
Documents
59
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20250331x10q.htm   iXBRL 10-Q 1283824
2 EX-10.1 capr-20250331xex10d1.htm EX-10.1 39219
3 EX-31.1 capr-20250331xex31d1.htm EX-31.1 10470
4 EX-31.2 capr-20250331xex31d2.htm EX-31.2 10205
5 EX-32.1 capr-20250331xex32d1.htm EX-32.1 5732
6 EX-32.2 capr-20250331xex32d2.htm EX-32.2 5720
  Complete submission text file 0001558370-25-007770.txt   5881869

Data Files

Seq Description Document Type Size
7 EX-101.SCH capr-20250331.xsd EX-101.SCH 48997
8 EX-101.CAL capr-20250331_cal.xml EX-101.CAL 40368
9 EX-101.DEF capr-20250331_def.xml EX-101.DEF 184001
10 EX-101.LAB capr-20250331_lab.xml EX-101.LAB 372035
11 EX-101.PRE capr-20250331_pre.xml EX-101.PRE 304741
62 EXTRACTED XBRL INSTANCE DOCUMENT capr-20250331x10q_htm.xml XML 846403
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 25946284
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)